Odyssey Health, Inc. cash flow statement ODYY

Annual Quarterly

In fiscal 2026, which ended Jul 31, 2026, Odyssey Health, Inc. used $1.0 million of cash from operations, down 201.2% from the year before.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line	FY 2026 Jul 31, 2026	FY 2025 Jul 31, 2025	FY 2024 Jul 31, 2024	FY 2023 Jul 31, 2022	FY 2021 Jul 31, 2021	FY 2021 Jul 31, 2020	FY 2019 Jul 31, 2019	FY 2018 Jul 31, 2018	FY 2017 Jul 31, 2017	FY 2016 Jul 31, 2016
Operating
Depreciation and amortization	—	—	0 -55.0%	0	0	0	0 +0.0%	0 -0.0%	0 +105.4%	0
Stock-based compensation	0 -95.0%	0 -81.2%	1	—	—	3	0	—	—	—
Operating cash flow	-1 -201.2%	-0 +71.4%	-1 +17.6%	-1	-3	-1	-0 +28.2%	-0 -25.3%	-0 -91.6%	-0 -132.7%
Investing
Capital expenditures	—	—	—	—	—	—	—	—	0 -100.0%	0
Investing cash flow	0 -100.0%	0 -93.0%	1	—	0	—	0	0	0 +100.0%	-0
Financing
Financing cash flow	1 +290.6%	0 +62.9%	0 -87.5%	1	3	1	0 +104.1%	0 +4.1%	0 +15.2%	0 +149.0%
Change in cash
Free cash flow	—	—	—	—	—	—	—	—	-0 -81.7%	-0
Ratios
Free cash flow margin	—	—	—	—	—	—	—	—	—	-171.34%
Capital expenditures to revenue	—	—	—	—	—	—	—	—	—	8.84%

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: ODYY (OTC)
Fiscal year ends: July 31
Incorporated in: NV
Headquarters: Las Vegas, NV
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1626644
Former names: Odyssey Group International, Inc. (until Feb 18, 2022)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.